European Surveillance of Antimicrobial Consumption (ESAC): quality indicators for outpatient antibiotic use in Europe.
about
Antibiotics and allergic disorders in childhoodApproaching the quality of antibiotic prescriptions in primary care using reimbursement data.Appropriate international measures for outpatient antibiotic prescribing and consumption: recommendations from a national data comparison of different measures.Improving antimicrobial prescribing in Irish primary care through electronic data collection and surveillance: a feasibility study.Trends in antibiotic use among outpatients in New Delhi, IndiaVariation in outpatient antibiotic prescribing in the United StatesSeasonality and Physician-related Factors Associated with Antibiotic Prescribing: A Cross-sectional Study in Isfahan, Iran.Antibiotic prescriptions and cycles of Mycoplasma pneumoniae infections in Norway: can a nationwide prescription register be used for surveillance?Effect of Physicians' Attitudes and Knowledge on the Quality of Antibiotic Prescription: A Cohort Study.Trends in number of consultations and antibiotic prescriptions for respiratory tract infections between 1999 and 2005 in primary healthcare in Kalmar County, Southern SwedenQuality indicators for diagnosis and treatment of respiratory tract infections in general practice: a modified Delphi study.Prescribing quality in medical specialists in isfahan, iran.Quality assessment of diagnosis and antibiotic treatment of infectious diseases in primary care: a systematic review of quality indicators.Access to antibiotics in New Delhi, India: implications for antibiotic policy.Antibiotic prescribing in relation to diagnoses and consultation rates in Belgium, the Netherlands and Sweden: use of European quality indicators.Overview of strategies for overcoming the challenge of antimicrobial resistance.Development and validation of the knowledge and attitudes regarding antibiotics and resistance (KAAR-11) questionnaire for primary care physicians.Indicators for assessing quality of drug use: A systematic literature review.Trends in antimicrobial prescribing rates for Alaska Native and American Indian persons <18 years of age residing in the Anchorage region.Trends and patterns of antibiotic consumption in Shanghai municipality, China: a 6 year surveillance with sales records, 2009-14.Patterns of antibiotic use in the community and challenges of antibiotic surveillance in a lower-middle-income country setting: a repeated cross-sectional study in Vellore, South India.Usefulness of quality indicators for antibiotic use: case study for the Netherlands.Use of antibiotics in paediatric primary care settings in Serbia.Quality indicators to measure appropriate antibiotic use in hospitalized adults.Quality of antibiotic prescription during office hours and out-of-hours in Flemish primary care, using European quality indicators.European Surveillance of Antimicrobial Consumption (ESAC): quality appraisal of antibiotic use in Europe.Quality indicators as a tool in improving the introduction of new medicines.Evolution, health and disease--Darwinian approaches to medicine.The quality of outpatient antimicrobial prescribing: a comparison between two areas of northern and southern Europe.National disparities in the relationship between antimicrobial resistance and antimicrobial consumption in Europe: an observational study in 29 countries.Time trends in antibiotic consumption in the elderly: Ten-year follow-up of the Spanish National Health Survey and the European Health Interview Survey for Spain (2003-2014).Antibiotic use and bacterial complications following upper respiratory tract infections: a population-based study.ECDC, EFSA and EMA Joint Scientific Opinion on a list of outcome indicators as regards surveillance of antimicrobial resistance and antimicrobial consumption in humans and food‐producing animalsTrends and patterns of antibiotic consumption in China's tertiary hospitals: Based on a 5 year surveillance with sales records, 2011-2015.Assessment of prescribing practices at the primary healthcare facilities in Botswana with an emphasis on antibiotics: Findings and implications.Comparing antibiotic consumption between two European countries: are packages an adequate surrogate for prescriptions?Sustainable reduction of antibiotic-induced antimicrobial resistance (ARena) in German ambulatory care: study protocol of a cluster randomised trial.Validity of prescribing indicators for assessing quality of antibiotic use in Australian general practice.Reduced antibiotic prescription rates following physician-targeted interventions in a dental practice.Has primary care antimicrobial use really been increasing? Comparison of changes in different prescribing measures for a complete geographic population 1995-2014.
P2860
Q28386230-12B7E620-F166-4889-B86B-C56CE79DD3CDQ30566077-FFC10FDB-BE2E-471A-B7F9-3533757E1EB6Q30670985-ED502C4D-1352-4E44-AD29-014027A13211Q30978227-80CC72F2-511D-4546-B5B4-10860AEB1E16Q33877859-A8D2DC62-37A7-42F8-A367-78C548684928Q34022347-89A18E2D-1B7E-4EFE-9165-CAFCDFDF067CQ35184021-33741AB8-3E4A-44A8-A6FD-CA99D1E51A59Q35686514-F2D399EE-053F-4E4C-8BB4-9B15517A6577Q35824512-44E88513-F79A-40F9-B213-4991BCCF013FQ36135451-E6998199-9E61-4C34-9EBE-5B6D63AD3FDDQ36230390-D4FE40BC-E855-49EE-B466-C9FD12C1E646Q37268349-890DE768-0144-41D5-A3FB-7E68A447922DQ37281882-B12CA0D7-CF9A-490F-88EF-8C81E555F576Q37703358-6EF1C8A8-3EC9-4659-A20B-8742AFF6AD4FQ37715164-5B0254ED-AE9F-415F-83A2-29F01EC76EE7Q37960104-E047FC02-AF8E-4C9E-BB8C-C3ED41203F1CQ38879988-D906D2F8-C1EF-45EB-AC5C-6954802DB83FQ38918806-62520443-C93D-4F2F-9A50-4D2B577D66DCQ39907949-865A20C7-4621-454F-9A82-E7DC081EF2A5Q39985664-60C74765-847A-4C48-B387-B6258DBE106BQ40060810-386ABEDB-0248-404C-A3E8-4DA2C0E246BDQ40528708-B2B84AC4-5096-48FE-A03A-E05DB09C1E70Q40918819-8E3AA931-6A00-4A10-975A-67F2F6E47B85Q41722684-29327CB0-63F0-407F-81AA-A8E9EC8853CEQ42249022-0E271B7F-1A39-4B93-9EEE-0986B68C3B26Q44133530-483BED1D-54B5-4DEB-96C3-F7D4BB62E4C6Q44695835-0930BA82-ABC1-4794-B144-E4BE16E9984AQ45084632-3145EF13-9AA8-447F-A0E7-96DD51AC4527Q45825921-4EFA114D-B62F-4E8F-B6CB-3CC838DC385FQ46298748-125F412B-85E4-4C47-B46A-2AF72F7CFFCBQ47126522-B9C78988-2E52-439A-A3F3-FCCA6146B612Q47156289-4050074E-A136-4A87-BA77-14F2B6CF8E6AQ47160764-8E3DC112-1352-4F74-BFD7-5CD6AC180800Q47242842-FDEC88AA-BAC7-40A8-9894-52E38C95FE3EQ47409589-6C08BC0E-5E82-4038-BAD9-904B3EC5B8E8Q47433884-C7E841AC-8DC6-4FB8-839A-7318E791D701Q48103710-0C8C7492-76B9-41B5-B649-5C23F748FD52Q48765798-E9A444F0-B637-47DE-B21D-DC499BB88F40Q49838992-4FCF1163-2774-46EE-AD18-0C568C9EBC44Q50221901-E45C2138-C03A-4E3D-801F-E997B2AAFF2B
P2860
European Surveillance of Antimicrobial Consumption (ESAC): quality indicators for outpatient antibiotic use in Europe.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
European Surveillance of Antim ...... ient antibiotic use in Europe.
@en
type
label
European Surveillance of Antim ...... ient antibiotic use in Europe.
@en
prefLabel
European Surveillance of Antim ...... ient antibiotic use in Europe.
@en
P2093
P2860
P50
P356
P1476
European Surveillance of Antim ...... ient antibiotic use in Europe.
@en
P2093
Chris C Butler
Dominique L Monnet
ESAC Project Group
Flora M Haaijer-Ruskamp
Matus Ferech
Robert H Vander Stichele
Theo J M Verheij
P2860
P304
P356
10.1136/QSHC.2006.021121
P577
2007-12-01T00:00:00Z